I appreciate Senators Kyne and Byrne bringing forward this motion and giving us the opportunity to discuss this important issue. It is timely as well because there are a couple of updates that I can give that will be helpful in this context. We have a shared goal in the motion to enhance our genetic and genomic capability and to deliver high-quality care alongside value for money for the State. We are on the same page and it is a particularly timely conversation. As a number of Members said, the value that genomics…